Protagonist Therapeutics
Robert Campbell is an accomplished professional in the field of analytical chemistry with extensive experience in the biopharmaceutical industry. Currently serving as Vice President of Analytical Chemistry at Protagonist Therapeutics since September 2017, Robert previously held roles such as Director of Analytical Chemistry at Principia Biopharma and Sr. Scientist at Achaogen. Robert's earlier career includes leadership positions at Theravance Biopharma, where Robert was Group Leader in Analytical Chemistry, and at Coulter Pharmaceuticals as an Associate Scientist in Formulations. Prior experience also includes a role as Sr. Chemist for Quality Control at Gilead Sciences and Jr. Analytical Chemist at Kolmar Laboratories. Robert holds a Master of Science in Biochemistry and a Bachelor of Applied Science in Biochemistry, both from the University of California, Riverside.
This person is not in any teams
This person is not in any offices
Protagonist Therapeutics
1 followers
Protagonist Therapeutics develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies.